Clinical Trial Update: Evaluation of Safety and Efficacy of realSKIN® (Skin Xenotransplant) for Complete Closure of Severe Burn Wounds [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 trial evaluating realSKIN (Skin Xenotransplant) for complete closure of severe deep full-thickness burn injuries has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Deep Full-thickness Burn Injury

Drugs mentioned

• realSKIN

Snippet

Sponsor: XenoTherapeutics, Inc. | Conditions: Deep Full-thickness Burn Injury (Disorder) | Phase 1, Phase 2 | Status: COMPLETED